Thyroid-stimulating hormone stimulates interleukin-6 release from 3T3-L1 adipocytes through a cAMP-protein kinase a pathway

Obesity Research

Volumn 13, Issue 12, 2005, Pages 2066-2071

  Antunes, Tayze T ^a   Gagnon, Annemarie ^a   Bell, Andrea ^a   Sorisky, Alexander ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Adipocyte; cAMP; Interleukin 6; Protein kinase A; Thyroid stimulating hormone

Indexed keywords

EID: 33645060226     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2005.256     Document Type: Review

References (33)

1. Davies TF, Marians R, Latif R. The TSH receptor reveals itself. J Clin Invest. 2002;110:161-4.
2. Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev. 2003;24:802-35.
3. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89:2548-56.
4. Sorisky A, Bell A, Gagnon A. TSH receptor in adipose cells. Harm Metab Res. 2000;32:468-74.
5. Janson A, Rawet H, Perbeck L, Marcus C. Presence of thyrotropin receptor in infant adipocytes. Pediatr Res. 1998;43:555-8.
6. Shintani M, Nishimura H, Akamizu T, et al. Thyrotropin decreases leptin production in rat adipocytes. Metabolism. 1999;48:1570-4.
7. Menendez C, Baldelli R, Camina JP, et al. TSH stimulates leptin secretion by a direct effect on adipocytes. J Endocrinol. 2003;176:7-12.
8. Bell A, Gagnon A, Sorisky A. TSH stimulates IL-6 secretion from adipocytes in culture. Arterioscler Thromb Vasc Biol. 2003;23:E65-6.
9. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab. 1997;82:4196-200.
10. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-74.
11. Hak AE, Pols HAP, Visser TJ, Drexhage HA, Hofman A, Witteman JCM. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Int Med. 2000;132:270-8.
12. Imaizumi M, Akahoshi M, Ichimaru S, et al. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab. 2004;89:3365-70.
13. Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol. 2004;61:232-8.
14. Franklyn JA, Sheppard MC, Maisonneuve P. Thyroid function and mortality in patients treated for hyperthyroidism. JAMA. 2005;294:71-80.
15. Christ-Crain M, Meier C, Guglielmetti M, et al. Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis. 2003;166:379-86.
16. Tuzcu A, Bahceci M, Gokalp D, Tuzun Y, Gunes K. Subclinical hypothyroidism may be associated with elevated high-sensitive c-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocr J. 2005;52:89-94.
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-5.
18. Path G, Bornstein SR, Gurniak M, Chrousos GP, Scherbaum WA, Hauner H. Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by β-adrenergic activation and effects of IL-6 on adipocyte function. J Clin Endocrinol Metab. 2001;86:2281-8.
19. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE, Roger PP. Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev. 2001;22:631-56.
20. Bell A, Gagnon A, Dods P, Papineau D, Tiberi M, Sorisky A. TSH signaling and cell survival in 3T3-L1 preadipocytes. Am J Physiol Cell Physiol. 2002;283:C1056-64.
21. Kopperud R, Krakstad C, Selheim F, Doskeland SO. cAMP effector mechanisms: novel twists for an "old" signaling system. FEBS Lett. 2003;546:121-6.
22. 2-adrenergic receptor. J Cell Biol. 2003;160:487-93.
23. Vandeput F, Perpete S, Coulonval K, Lamy F, Dumont JE. Role of the different mitogen-activated protein kinase subfamilies in the stimulation of dog and human thyroid epithelial cell proliferation by cyclic adenosine 5′-monophosphate and growth factors. Endocrinology. 2003;144:1341-9.
24. Rodbell M. Metabolism of isolated fat cells. J Biol Chem. 1964;239:375-80.
25. Haraguchi K, Shimura H, Kawaguchi A, Ikeda M, Endo T, Onaya T. Effects of thyrotropin on the proliferation and differentiation of cultured rat preadipocytes. Thyroid. 1999;9:613-9.
26. Ross SE, Hemati N, Longo KA, et al. Inhibition of adipogenesis by Wnt signaling. Science. 2000;289:950-53.
27. Stephens JM, Butts MD, Pekala PH. Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumour necrosis factor-alpha. J Mo Endocrinol. 1992;9:61-72.
28. Fasshauer M, Klein J, Lossner U, Paschke R. Interleukin (IL)-6 mRNA expression is stimulated by insulin, isoproterenol, tumour necrosis factor alpha, growth hormone, and IL-6 in 3T3-L1 preadipocytes. Horm Metab Res. 2003;35:147-52.
29. Serazin-Leroy V, Morot M, de Mazancourt P, Giudicelli Y. Differences in type II, IV, V and VI adenylyl cyclase isoform expression between rat preadipocytes and adipocytes. Biochim Biophys Acta. 2001;1550:37-51.
30. Bell A, Gagnon A, Grunder L, Parikh SJ, Smith TJ, Sorisky A. Functional TSHR receptor in human abdominal preadipocytes and orbital fibroblasts. Am J Physiol Cell Physiol. 2000;279:C335-40.
31. Harkins JM, Moustaid-Moussa N, Chung YJ, et al. Expression of interleukin-6 is greater in preadipocytes than in adipocytes of 3T3-L1 cells and C57BL/6J and ob/ob mice. J Nutr. 2004;134:2673-7.
32. Dremier S, Vandeput F, Zwartkruis FJT, Bos JL, Dumont JE, Maenhaut C. Activation of the small G protein Rapl in dog thyroid cells by both cAMP-dependent and -independent pathways. Biochem Biophys Res Commun. 2000;267:7-11.
33. Vanvooren V, Allgeier A, Nguyen M, et al. Mutation analysis of the Epac-Rap1 signaling pathway in cold thyroid follicular adenomas. Eur J Endocrinol. 2001;144:605-10.